Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 5/2012

01-05-2012 | Thoracic Oncology

The Role of Adjuvant Chemotherapy for Localized Squamous Cell Esophageal Cancer: Current Japanese Standard and the Unending Role of the Drawing Board

Authors: Yuko Kitagawa, MD, Nobutoshi Ando, MD, Kenichi Nakamura, MD, Taro Shibata, MD, Haruhiko Fukuda, MD

Published in: Annals of Surgical Oncology | Issue 5/2012

Login to get access

Excerpt

Esophageal cancer is the sixth most common cause of death for men and, among the various gastrointestinal malignancies, it is considered to possess a relatively high malignant potential. Major causes of the difficulties in the management of this clinical entity are largely related to its clinicopathological characteristics, particularly the high frequency of complex patterns of lymph node metastasis. …
Literature
1.
Gebski V, Burmeister B, Smithers BM, et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol. 2007;8:226–34.PubMedCrossRef
2.
Ando N, Kato H, Igaki H, Shinoda M, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. doi:10.​1245/​s10434-011-2049-9 PubMedCrossRef
3.
4.
Ando N, Iizuka T, Ide H, et al. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study JCOG9204. J Clin Oncol. 2003;21:4592–6.PubMedCrossRef
5.
Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data, 2nd edn. Hoboken: Wiley, 2002:22-3.CrossRef
6.
Green S, Benedetti J, Crowley J. Competing risks. In: Clinical trials in oncology, 2nd edn. Boca Raton: Chapman and Hall/CRC, 2003:188–94.
7.
Tsiatis AA. Competing risks. In: Armitage P, Colton T, eds. Encyclopedia of biostatistics, 2nd edn. Chichester: Wiley, 2005:1025.
Metadata
Title
The Role of Adjuvant Chemotherapy for Localized Squamous Cell Esophageal Cancer: Current Japanese Standard and the Unending Role of the Drawing Board
Authors
Yuko Kitagawa, MD
Nobutoshi Ando, MD
Kenichi Nakamura, MD
Taro Shibata, MD
Haruhiko Fukuda, MD
Publication date
01-05-2012
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 5/2012
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-012-2250-5

Other articles of this Issue 5/2012

Annals of Surgical Oncology 5/2012 Go to the issue

Gastrointestinal Oncology

DOK2 as a Marker of Poor Prognosis of Patients with Gastric Adenocarcinoma After Curative Resection

Breast Oncology

Scoring System Based on BI-RADS Lexicon to Predict Probability of Malignancy in Suspicious Microcalcifications

Translational Research and Biomarkers

Serum HE4 Level is an Independent Prognostic Factor in Epithelial Ovarian Cancer

Hepatobiliary Tumors

Outcome of Microscopic Incomplete Resection (R1) of Colorectal Liver Metastases in the Era of Neoadjuvant Chemotherapy

Thoracic Oncology

Changes in Age, Stage Distribution, and Survival of Patients with Esophageal Adenocarcinoma over Three Decades in the United States

Breast Oncology

Six-Year Analysis of Treatment-Related Toxicities in Patients Treated with Accelerated Partial Breast Irradiation on the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial